We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Touts FDA Plans for Up-Front Review of Oncology Trial Data
Gottlieb Touts FDA Plans for Up-Front Review of Oncology Trial Data
A new FDA pilot program would pre-review sponsors’ data submissions to reduce delays in oncology drug development, FDA Commissioner Scott Gottlieb said Saturday.